Ann: Trading Halt, page-12

TBH, I consider any deal under the .05c option deal ( .50c equivalent now) a great entry price for any entity, particularly with activities such as the launch of GTH Pro and FDA submission for Pulse having de-risked CDX since then, IMO.

My hope is that a considerable sum has been raised and we have a clear runway for at least the next 18 months, allowing the activity set ( Pulse and Band ) to be delivered, and revenue flowing in. In theory, after the initial reaction to the offer price, this should release the handbrake on the MC even with the resultant dilution from the CR.

GLTAH